Marie Classon,Gulfem Dilek Guler,Robert Pitti,Jean-Philippe Stephan,Charles Albert Tindell
申请号：
US15321625
公开号：
US20170209444A1
申请日:
2015.06.23
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Provided herein are methods of using antagonists of G9a, for example, for treating cancer and/or preventing drug resistance in an individual. For example, a method of treating cancer in an individual comprising administering to the individual an antagonist of G9a alone or in combination with a cancer therapy agent is provided. In some embodiments, the antagonist of G9a increases the period of cancer sensitivity and/or delays development of cancer resistance.
